Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

Inflammatory Bowel Diseases

Free Subscription 02.10.2023 3 Aliment Pharmacol Ther 1 Am J Gastroenterol 3 BMC Gastroenterol 4 Clin Gastroenterol Hepatol 1 Clin Res Hepatol Gastroenterol 1 Dig Dis 2 Dig Dis Sci 2 Gastroenterology 5 Inflamm Bowel Dis

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Aliment Pharmacol Ther

1. ANDREW B, Zhou A, Trinh S, Srinivasan A, et al
   Letter: Antibiotics in gut dysbiosis and development of inflammatory bowel disease-More thought is needed.
   Aliment Pharmacol Ther. 2023;58:838-839.
   PubMed        
   
   
2. OH SJ, Kim HJ, Lee CK
   Letter: Antibiotics in gut dysbiosis and development of inflammatory bowel disease-More thought is needed-Authors' reply.
   Aliment Pharmacol Ther. 2023;58:840-841.
   PubMed        
   
   
3. VAN DE MEEBERG MM, Fidder HH, Oldenburg B, Sundaresan J, et al
   Therapeutic drug monitoring of methotrexate in patients with Crohn's disease.
   Aliment Pharmacol Ther. 2023 Sep 28. doi: 10.1111/apt.17719.
   PubMed         Abstract available
   
   

   
   Am J Gastroenterol

4. ALSOUD D, Ho J, Sabino J, Ferrante M, et al
   Utility of the Serum-Based Endoscopic Healing Index in Monitoring Therapeutic Response in Ulcerative Colitis.
   Am J Gastroenterol. 2023 Sep 27. doi: 10.14309/ajg.0000000000002518.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

5. HU X, Li J, Sun Y, Wu D, et al
   Combined use of CDAI and blood indices for assessing endoscopic activity in ileocolic Crohn's disease.
   BMC Gastroenterol. 2023;23:337.
   PubMed         Abstract available
   
   
6. RANA VS, Mahajan G, Patil AN, Singh AK, et al
   Factors contributing to flares of ulcerative colitis in North India- a case-control study.
   BMC Gastroenterol. 2023;23:336.
   PubMed         Abstract available
   
   
7. NA JE, Hong SN, Kim JE, Kim ER, et al
   Can balloon-assisted enteroscopy predict disease outcomes in patients with small-bowel Crohn's disease?
   BMC Gastroenterol. 2023;23:331.
   PubMed         Abstract available
   
   

   
   Clin Gastroenterol Hepatol

8. BICKSTON SJ, Kaur H
   Higher Rates of Smoking Cessation as a Cause for a Rise in Pouchitis.
   Clin Gastroenterol Hepatol. 2023;21:2988-2989.
   PubMed        
   
   
9. ULRICH JA, Habash NW, Ismail YA, Tremaine WJ, et al
   Effectiveness of Hepatitis B Vaccination for Patients With Inflammatory Bowel and Celiac Disease.
   Clin Gastroenterol Hepatol. 2023;21:2901-2907.
   PubMed         Abstract available
   
   
10. COLOMBEL JF, Ungaro RC, Sands BE, Siegel CA, et al
    Vedolizumab, Adalimumab, and Methotrexate Combination Therapy in Crohn's Disease (EXPLORER).
    Clin Gastroenterol Hepatol. 2023 Sep 22:S1542-3565(23)00746.
    PubMed         Abstract available
    
    
11. WILS P, Jairath V, Sands BE, Reinisch W, et al
    Washout periods in inflammatory bowel disease trials: A systematic literature review and proposed solutions.
    Clin Gastroenterol Hepatol. 2023 Sep 22:S1542-3565(23)00747.
    PubMed        
    
    

    
    Clin Res Hepatol Gastroenterol

12. ZHANG C, Liu X
    Fundamental crosstalk between circadian rhythm and the intestine in the pathogenesis of inflammatory bowel disease.
    Clin Res Hepatol Gastroenterol. 2023;47:102214.
    PubMed         Abstract available
    
    

    
    Dig Dis

13. YANG MM, Usiskin K, Ahmad HA, Ather S, et al
    Considerations for Colorectal Neoplasia Detection in Inflammatory Bowel Disease Clinical Trials.
    Dig Dis. 2023 Sep 27. doi: 10.1159/000533395.
    PubMed         Abstract available
    
    

    
    Dig Dis Sci

14. MAAS L, Gao R, Cusumano V, Spartz E, et al
    Superior Efficacy of Infliximab Versus Adalimumab for First-Line Treatment of Crohn's Perianal Fistulae.
    Dig Dis Sci. 2023;68:3994-4000.
    PubMed         Abstract available
    
    
15. DALAL RS, Baranov E, Li J, Hong X, et al
    Small Cells, Big Problems: Small Cell Carcinoma of the Rectal Cuff After Ileal-Pouch Anal Anastomosis in a Patient with Ulcerative Colitis.
    Dig Dis Sci. 2023 Sep 22. doi: 10.1007/s10620-023-08110.
    PubMed        
    
    

    
    Gastroenterology

16. YARUR AJ, Bruss A, Moosreiner A, Beniwal-Patel P, et al
    Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation Study.
    Gastroenterology. 2023;165:963-975.
    PubMed         Abstract available
    
    
17. CHEN J, Yang Q, Wang C
    Multiple Hepatic Masses in a Patient with Crohn's disease.
    Gastroenterology. 2023 Sep 20:S0016-5085(23)05014.
    PubMed        
    
    

    
    Inflamm Bowel Dis

18. CATASSI G, D'Arcangelo G, Norsa L, Bramuzzo M, et al
    Outcome of Very Early Onset Inflammatory Bowel Disease Associated With Primary Sclerosing Cholangitis: A Multicenter Study From the Pediatric IBD Porto Group of ESPGHAN.
    Inflamm Bowel Dis. 2023 Sep 28:izad218. doi: 10.1093.
    PubMed         Abstract available
    
    
19. METWALY A, Haller D
    The TNF?ARE Model of Crohn's Disease-like Ileitis.
    Inflamm Bowel Dis. 2023 Sep 26:izad205. doi: 10.1093.
    PubMed         Abstract available
    
    
20. LIU GXH, Day AS
    Plant-based Diets for Inflammatory Bowel Disease: What Is the Evidence?
    Inflamm Bowel Dis. 2023 Sep 25:izad213. doi: 10.1093.
    PubMed         Abstract available
    
    
21. PATEL R, Marrie RA, Bernstein CN, Bolton JM, et al
    Vascular Disease Is Associated With Differences in Brain Structure and Lower Cognitive Functioning in Inflammatory Bowel Disease: A Cross-Sectional Study.
    Inflamm Bowel Dis. 2023 Sep 22:izad204. doi: 10.1093.
    PubMed         Abstract available
    
    
22. SIGVARDSSON I, Stordal K, Ostensson M, Guo A, et al
    Childhood Socioeconomic Characteristics and Risk of Inflammatory Bowel Disease: A Scandinavian Birth Cohort Study.
    Inflamm Bowel Dis. 2023 Sep 22:izad220. doi: 10.1093.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.